Seeking Alpha

Pluristem Therapeutics (PSTI +4%) pops on reports that the FDA has granted orphan status for its...

Pluristem Therapeutics (PSTI +4%) pops on reports that the FDA has granted orphan status for its PLX Cells to treat aplastic anemia.
Comments (1)
  • smallcap sleuth
    , contributor
    Comments (182) | Send Message
     
    How come the likely profitability is so far into the future if this can be brought to market sooner?
    21 Feb 2013, 05:03 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|